340 related articles for article (PubMed ID: 31808385)
1. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
[TBL] [Abstract][Full Text] [Related]
2. Nanocarrier based approaches for targeting breast cancer stem cells.
Pindiprolu SKSS; Krishnamurthy PT; Chintamaneni PK; Karri VVSR
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):885-898. PubMed ID: 28826237
[TBL] [Abstract][Full Text] [Related]
3. Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance.
Palomeras S; Ruiz-Martínez S; Puig T
Molecules; 2018 Aug; 23(9):. PubMed ID: 30200262
[TBL] [Abstract][Full Text] [Related]
4. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy.
Das PK; Zahan T; Abdur Rakib M; Khanam JA; Pillai S; Islam F
Anticancer Agents Med Chem; 2019; 19(15):1796-1808. PubMed ID: 31272363
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer stem cells: a novel therapeutic target.
Gangopadhyay S; Nandy A; Hor P; Mukhopadhyay A
Clin Breast Cancer; 2013 Feb; 13(1):7-15. PubMed ID: 23127340
[TBL] [Abstract][Full Text] [Related]
7. Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells.
Pavlopoulou A; Oktay Y; Vougas K; Louka M; Vorgias CE; Georgakilas AG
Cancer Lett; 2016 Oct; 380(2):485-493. PubMed ID: 27450721
[TBL] [Abstract][Full Text] [Related]
8. Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting.
Lv L; Shi Y; Wu J; Li G
Int J Nanomedicine; 2021; 16():1487-1508. PubMed ID: 33654398
[TBL] [Abstract][Full Text] [Related]
9. Understanding EGFR Signaling in Breast Cancer and Breast Cancer Stem Cells: Overexpression and Therapeutic Implications.
Alanazi IO; Khan Z
Asian Pac J Cancer Prev; 2016; 17(2):445-53. PubMed ID: 26925626
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer stem cells: Biology and therapeutic implications.
Butti R; Gunasekaran VP; Kumar TVS; Banerjee P; Kundu GC
Int J Biochem Cell Biol; 2019 Feb; 107():38-52. PubMed ID: 30529656
[TBL] [Abstract][Full Text] [Related]
11. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
Ge G; Zhou C; Ren Y; Tang X; Wang K; Zhang W; Niu L; Zhou Y; Yan Y; He J
Tumour Biol; 2016 Apr; 37(4):5049-62. PubMed ID: 26546432
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cell in breast cancer therapeutic resistance.
Bai X; Ni J; Beretov J; Graham P; Li Y
Cancer Treat Rev; 2018 Sep; 69():152-163. PubMed ID: 30029203
[TBL] [Abstract][Full Text] [Related]
13. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
[TBL] [Abstract][Full Text] [Related]
14. Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.
Xie X; Huang X; Tang H; Ye F; Yang L; Guo X; Tian Z; Xie X; Peng C; Xie X
Curr Cancer Drug Targets; 2018; 18(6):592-599. PubMed ID: 29110616
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer stem cell: the roles and therapeutic implications.
Yang F; Xu J; Tang L; Guan X
Cell Mol Life Sci; 2017 Mar; 74(6):951-966. PubMed ID: 27530548
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer stem cells as novel biomarkers.
Ray SK; Mukherjee S
Clin Chim Acta; 2024 Apr; 557():117855. PubMed ID: 38453050
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor/heat shock protein 27 pathway regulates vasculogenic mimicry activity of breast cancer stem/progenitor cells.
Lee CH; Wu YT; Hsieh HC; Yu Y; Yu AL; Chang WW
Biochimie; 2014 Sep; 104():117-26. PubMed ID: 24950183
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cells in solid and liquid tissues of breast cancer patients: characterization and therapeutic perspectives.
Chiotaki R; Polioudaki H; Theodoropoulos PA
Curr Cancer Drug Targets; 2015; 15(3):256-69. PubMed ID: 25669721
[TBL] [Abstract][Full Text] [Related]
19. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
20. A recombinant protein TmSm(T34A) can inhibit proliferation and proapoptosis to breast cancer stem cells(BCSCs) by down-regulating the expression of Cyclin D1.
Ma X; Zhang Y; Kang Y; Li L; Zheng W
Biomed Pharmacother; 2016 Dec; 84():373-381. PubMed ID: 27668537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]